Surgical Financial Statements From 2010 to 2024
| SUSRF Stock | USD 12.75 0.00 0.00% |
Check Surgical Science financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgical Science's main balance sheet or income statement drivers, such as , as well as many indicators such as . Surgical financial statements analysis is a perfect complement when working with Surgical Science Valuation or Volatility modules.
Surgical |
Surgical Science Sweden Company Return On Equity Analysis
Surgical Science's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Surgical Science Return On Equity | 0.0357 |
Most of Surgical Science's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgical Science Sweden is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Surgical Science Sweden has a Return On Equity of 0.0357. This is 100.15% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The return on equity for all United States stocks is 111.52% lower than that of the firm.
Surgical Science Sweden Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Surgical Science's current stock value. Our valuation model uses many indicators to compare Surgical Science value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Surgical Science competition to find correlations between indicators driving Surgical Science's intrinsic value. More Info.Surgical Science Sweden is currently regarded as top stock in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about 0.59 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Surgical Science Sweden is roughly 1.68 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Surgical Science's earnings, one of the primary drivers of an investment's value.About Surgical Science Financial Statements
Surgical Science stakeholders use historical fundamental indicators, such as Surgical Science's revenue or net income, to determine how well the company is positioned to perform in the future. Although Surgical Science investors may analyze each financial statement separately, they are all interrelated. For example, changes in Surgical Science's assets and liabilities are reflected in the revenues and expenses on Surgical Science's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Surgical Science Sweden. Please read more on our technical analysis and fundamental analysis pages.
Surgical Science Sweden AB develops and markets virtual reality simulators for evidence-based laparoscopic and endoscopic training. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden. Surgical Science is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Surgical Pink Sheet
Surgical Science financial ratios help investors to determine whether Surgical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Surgical with respect to the benefits of owning Surgical Science security.